| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 05/21/2002 | CA2037664C Monoclonal antibody against complexed and noncomplexed complexing agents for removing heavy metals from aqueous solutions and for analysis |
| 05/16/2002 | WO2002039123A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | WO2002039120A1 A method for identifying the proteome of cells using an antibody library microarray |
| 05/16/2002 | WO2002038805A2 Eukaryotic cell division genes and their use in diagnosis and treatment of proliferative diseases |
| 05/16/2002 | WO2002038803A2 Novel marker for the diagnosis and therapy of tumours |
| 05/16/2002 | WO2002038795A2 Braf35 protein and brca2/braf35 complex and methods of use |
| 05/16/2002 | WO2002038766A2 Human tumor necrosis factor receptor |
| 05/16/2002 | WO2002038744A2 Proteases |
| 05/16/2002 | WO2002038732A2 Human testis specific serine/threonine kinase |
| 05/16/2002 | WO2002038730A2 Novel human potassium channel beta subunit |
| 05/16/2002 | WO2002038612A2 Canine and feline tumour-associated antigen 5t4 |
| 05/16/2002 | WO2002038611A2 Method of producing antibodies by immunization with conjugates of molecules coupled to charge-modified proteins |
| 05/16/2002 | WO2002038607A2 A 'bach' g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | WO2002038600A2 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | WO2002038597A2 Genomic fragment of streptococcus suis and clinical uses thereof |
| 05/16/2002 | WO2002038594A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/16/2002 | WO2002038177A2 Adjuvant combination formulations |
| 05/16/2002 | WO2002038173A1 Vaccine based on a cellular penetration factor from an apicomplexan parasite |
| 05/16/2002 | WO2002038168A2 Use of selectin-binding active ingredients for the treatment of inflammatory and tumoral diseases |
| 05/16/2002 | WO2002038162A1 MODIFIED FACTOR VIIa |
| 05/16/2002 | WO2002037967A1 Methods for generating genetically altered antibody-producing cell lines with improved antibody characteristics |
| 05/16/2002 | WO2002002640A3 Antibodies to human mcp-1 |
| 05/16/2002 | WO2001092496A3 Isolated human kinase proteins, nucleic acid molecules encoding human kinase proteins, and uses thereof |
| 05/16/2002 | WO2001092469A3 Phosphorylated polypeptides and uses related thereto |
| 05/16/2002 | WO2001092291A3 Antibody and t-cell receptor libraries |
| 05/16/2002 | WO2001087335A3 Method for selectively inhibiting ghrelin action |
| 05/16/2002 | WO2001085789A3 Extracellular domain of ryk protein for regulating angiogenesis |
| 05/16/2002 | WO2001081599A3 Protection against environmental toxicity through manipulation of the processing of messenger rna precursors |
| 05/16/2002 | WO2001079492A3 Lipid binding protein 3 |
| 05/16/2002 | WO2001075109A3 Antagonist antibodies to ve-cadherin without adverse effects on vascular permeability |
| 05/16/2002 | WO2001073049A3 33877 and 47179, human glycosyl transferase family members and uses thereof |
| 05/16/2002 | WO2001058526A3 Mixtures of caspase inhibitors and complement inhibitors and methods of use thereof |
| 05/16/2002 | WO2001048163A3 Dioxygenases catalyzing the asymetric cleavage of beta-carotene |
| 05/16/2002 | WO2001047959A3 Isolated nucleic acid molecules encoding cancer associated antigens, the antigens per se, and uses thereof |
| 05/16/2002 | WO2001044299A3 Antibodies and a method for producing same, the use thereof and immunisation cocktails, immunoassay-sets and peptides |
| 05/16/2002 | WO2001040521A3 Nucleic acids containing single nucleotide polymorphisms and methods of use thereof |
| 05/16/2002 | WO2001034636A9 Gridlock nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 05/16/2002 | WO2001032128A9 Human chemokine beta-13 |
| 05/16/2002 | WO2001029255A3 Diagnostic test for cephalic pain |
| 05/16/2002 | WO2001023428A3 Interleukin-2 receptor associated polypeptides |
| 05/16/2002 | US20020059653 Modulating protein complex formation in cells; obtain sample tissue, incubate with acetylcholine esterase, expose to modulator, monitor sample for complex formation |
| 05/16/2002 | US20020058800 Compositions and methods for the diagnosis and treatment of immune disorders |
| 05/16/2002 | US20020058798 Antibodies for use in the treatment of tumors |
| 05/16/2002 | US20020058797 Nef-attachable protein, DNA encoding the protein and a monoclonal antibody against said protein |
| 05/16/2002 | US20020058324 Protein recovery |
| 05/16/2002 | US20020058322 DNA molecules encoding fibrinolytically active polypeptide |
| 05/16/2002 | US20020058309 Nucleotide sequences for use in the treatment of nervous system disorders and neuronal damage |
| 05/16/2002 | US20020058294 Screening sample for botulin toxins; obtain sample, incubate with antibody, remove unbound antibody, incubate with avidin linked enzyme, measure optical density |
| 05/16/2002 | US20020058291 Forms of prostate specific antigens and methods for their detection |
| 05/16/2002 | US20020058289 Novel antibody compositions for preparing enriched mesenchymal progenitor preparations |
| 05/16/2002 | US20020058288 Compound for use in the detection and prevention of parasitic infection of humans |
| 05/16/2002 | US20020058285 Generating monoclonal antibody; obtain antigen, immunize nonmammal, immortalize immune response, recover monoclonal antibodies |
| 05/16/2002 | US20020058284 Methods and compositions for treating macrophage-mediated diseases |
| 05/16/2002 | US20020058267 Nucleotide sequences coding polypeptide for use in the treatment of alzheimer's disease |
| 05/16/2002 | US20020058264 Human regulatory molecules |
| 05/16/2002 | US20020058257 Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1 |
| 05/16/2002 | US20020058251 Observing the distribution of MN/CA9 antigen expressed on atypical or normal cells; atypical glandular cells of undetermined significance (AGUS) |
| 05/16/2002 | US20020058247 Synthetic peptides that bind to the hepatitis B virus core and e antigens |
| 05/16/2002 | US20020058241 Antibody for use in the treatment of prostate cancer |
| 05/16/2002 | US20020058046 Vaccines against neosporosis useful in the prevention of clinical disease and abortion in mammals. |
| 05/16/2002 | US20020058044 LVPs associated with human immunoglobulins having a density of less than 1.063 g/ml. |
| 05/16/2002 | US20020058038 Specific octapeptides, antibodies that recognize and bind to these compounds, polynucleotides that encode these compounds and immune effector cells raised in response to presentation of these epitopes. |
| 05/16/2002 | US20020058037 Use of anti-gp-39 antibodies for treatment and/or reversal of lupus and lupus associated kidney disease |
| 05/16/2002 | US20020058036 Novel fibroblast growth factor and nucleic acids encoding same |
| 05/16/2002 | US20020058034 Treating or ameliorating an autoimmune condition, an allergic reaction or asthma |
| 05/16/2002 | US20020058033 Human anti-epidermal growth factor receptor single-chain antibodies |
| 05/16/2002 | US20020058031 Utilizes human antibodies to identify and produce antigen preparations that are useful for detection, diagnosis, prognosis or prevention of human etiological agents or human disease states or conditions. |
| 05/16/2002 | US20020058029 Anti-CD40L, anti-B7.1 (CD80), anti-B7.2(CD86), CD40 antibody or anti-CD4 antibody; both may be administered separately or in combination, and in any order. |
| 05/16/2002 | US20020058024 Modulators of the function of receptors of the TNF/NGF receptor family and other proteins |
| 05/16/2002 | US20020058022 Novel compounds |
| 05/16/2002 | US20020058019 Simultaneous stimulation and concentration of cells |
| 05/16/2002 | DE10056136A1 Inhibiting leukocyte or tumor cell adhesion to vascular endothelial cells e.g. for combating inflammation or metastasis, using e.g. pregnancy proteins or selectin binding liposomes containing calcium-binding compound |
| 05/16/2002 | DE10048727A1 Monoklonale Antikörper gegen humanes Cathepsin W und/oder Pro-cathepsin W mit definierter Epitopspezifität, deren Herstellung und Verwendung Monoclonal antibodies against human cathepsin W and / or pro-cathepsin W with a defined epitope, their preparation and use |
| 05/16/2002 | DE10044002A1 F¶v¶-Konstrukte mit beeinflußbarer Affinität zu einer zu bindenden Substanz F¶v¶ constructs with suggestible affinity for a substance to be bound |
| 05/16/2002 | CA2429000A1 Adjuvant combination formulations |
| 05/16/2002 | CA2428453A1 C. elegans genes involved in viability and/or reproduction and uses thereof |
| 05/16/2002 | CA2428368A1 Kit and method for detecting the esm-1 protein |
| 05/16/2002 | CA2428242A1 Human tumor necrosis factor receptor |
| 05/16/2002 | CA2428241A1 Novel human potassium channel beta subunit |
| 05/16/2002 | CA2428141A1 Use of selectin-binding pregnancy proteins, liposomes, native mucin fragments and mimetic compounds for the treatment and prophylaxis of inflammatory diseases, for preventing metastatic spread and for the prophylaxis of tumour diseases |
| 05/16/2002 | CA2426037A1 A "bach" g protein coupled receptor polypeptide and polynucleotide encoding this receptor |
| 05/16/2002 | CA2425829A1 Proteases |
| 05/16/2002 | CA2399276A1 Novel therapeutic compositions for treating infection by lawsonia spp |
| 05/15/2002 | EP1205552A1 Virulence of streptococci, involving ORFs from Streptococcus suis |
| 05/15/2002 | EP1205550A1 Polypeptides and nucleic acids encoding the same |
| 05/15/2002 | EP1205547A2 DNA mutagenesis by random fragmentation and reassembly |
| 05/15/2002 | EP1205546A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1205489A1 Polypeptide and nucleic acids encoding the same |
| 05/15/2002 | EP1204868A1 Cancer treatments and diagnostics utilizing rad51 related molecules and methods |
| 05/15/2002 | EP1204764A2 Methods of screening for angiogenesis modulators |
| 05/15/2002 | EP1204757A1 Neutral cerebral-sphingomyelinase |
| 05/15/2002 | EP1204754A2 Polynucleotides expressed in activated t-lymphocytes and proteins encoded thereby |
| 05/15/2002 | EP1204752A2 Immunogenic polypeptides derived from moraxella catarrhalis and uses thereof |
| 05/15/2002 | EP1204748A2 New g-protein coupled receptor and dna sequences thereof |
| 05/15/2002 | EP1204747A1 G protein-coupled receptor expressed in brain |
| 05/15/2002 | EP1204744A1 Isolated peptide of the horny layer and use thereof |
| 05/15/2002 | EP1204683A1 Ovarian cancer cell and myeloma cell surface glycoproteins, antibodies thereto, and uses thereof |
| 05/15/2002 | EP1204682A2 Compositions and methods for the treatment of tumors |
| 05/15/2002 | EP1204681A2 Helical cytokine zalpha48 |
| 05/15/2002 | EP1204678A1 Moraxella cattarrhalis basb114 antigens and uses thereof |